Team:TU-Delft/PeptideCharacterization

From 2013.igem.org

(Difference between revisions)
Line 270: Line 270:
</center>
</center>
<center>
<center>
-
<p>Figure 5: SebastiniDim<br><br></p></div></center>
+
<p>Figure 5: MICs of SebastiniDim<br><br></p></div></center>
<br>
<br>
</p>
</p>

Revision as of 12:21, 2 October 2013


Peptide Characterization

An important part of the project is inhibition of growth or killing of bacteria with the use of antimicrobial peptides (AMPs). In order to get an idea of the toxicity of our peptides we conducted several minimal inhibiting concentration (MIC) experiments. These MIC measurements where done on E. coli, B. subtilis andS. delphini, with the first as representative of our Gram-negative expression host, the second for the Gram-positive targets and the last for our specific target. The AMPs Signiferin, maximin H5 and magainin were chosen from literature [1,2,3] as being active against staphylococcus species but not against E. coli in order to able to use the latter as the expression host. MICs were also determined for the novel peptides we designed as described ( here).



Procedure

  1. Grow the appropriate strains overnight and make a 1/50 to 1/100 dilution the next morning and wait for the OD at 600nm to reach 0,4-0,6.
  2. Make a 100µM stock of the AMP in LB medium, this solution will serve as a 100 X stock, as the expected MIC range of our AMPs lays between 5 and 40 µM.
  3. Then make the combinations as shown in table 1 in a 96 well plate, for the plate reader to take readings using an plate reader capable of shaking and heating to 37˚C. Taking measurements every 10 minutes.

No cells + 1mM 40µM 30µM 25µM 20µM 15µM 10µM 7.5µM 5.0µM 2.0µM 1.0µM Cell + No AMP
LB(µL) 90 55 65 70 91 75 80 85 87.5 90 93 94
Cells(µL) - 5 5 5 5 5 5 5 5 5 5 5
100μΜ(µL) 10 40 30 25 20 15 10 7.5 5.0 2.0 1.0 -

Results


MIC determination

The MIC of signiferin on S. delphini, B. subtilis and E. coli were done according to the protocol described above. S. delphini is the most sensitive for signiferin, as the MIC was determined to be 1µM (Figure 1A), no growth is seen at this concentration. The MIC for B. subtilis was determined to be 10µM (Figure 1B).

Figure 1: MICs of Maximim-H5


The expected selectivity of the chosen peptides for Staphylococcus was confirmed by these experiments, as for all the peptides for which we could determine a MIC, that MIC was the lowest on S. delphini. Maximin H5 and magainin did not give a measurable reduction in growth below 40µM (Figure 2), making us decide not to proceed testing, as modelingshowed it was not possible to reach these concentrations through expression in E.coli.


Figure 2: MICs of Maximim-H5 and Magainin


The fact that for none of the peptides a MIC could be determined for E. coli (>150µM) further confirms the expected selectivity towards Gram-positives (Figure 3).

Figure 3: MICs of Maximim-H5, Signiferin and Magainin in E.coli

Of the novel peptides two were determined to be active against S. delphini; sebastini and joepini, with MICs of respectively 30 and 40µM (Figure 4, Figure 5). .The MIC of sebastini on B. subtilis however was determined to be <10µM (Figure 5B) lower than that for S. delphini. As for the peptides described above, no MIC could be determined for E.coli (Figure 6).

Figure 4: MICs of JoepininMat


Figure 5: MICs of SebastiniDim



References

  1. V.M. Maselli, D. Bilusich, et al., Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry, Rapid Communications in Mass Spectrometry, Volume 20, Issue 5, pages 797–803, Mar 2006.
  2. Lai R, Liu H, et al., An anionic antimicrobial peptide from toad Bombina maxima, Biochem Biophys Res Commun, 26;295(4):796-9, Jul 2002
  3. M. Zasloff, Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor, Proc Natl Acad Sci U S A.;84(15):5449-53 Aug 1987.
  4. J.F. Hancock, “COS Cell Expression”, Methods in Molecular Biology. Vol 8 pp 153-158, 1992.
  5. Fred C. Jensen, Anthony J. Girardi, et al., “Infection of Human and Simian Tissue Cultures with Rous Sarcoma Virus”, Proc Natl Acad Sci U S A. 1964 July; 52(1): 53–59. Jul 1964.
  6. P. Shashidharan, G.W. Huntley, et al., “Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody, Brain Research. Volume 773, Issues 1–2, Pages 139–148, Okt 1997.
Retrieved from "http://2013.igem.org/Team:TU-Delft/PeptideCharacterization"